86 related articles for article (PubMed ID: 932487)
1. Percutaneous penetration and metabolism of topical (14C)flutamide in men.
Katchen B; Dancik S; Millington G
J Invest Dermatol; 1976 Jun; 66(6):379-82. PubMed ID: 932487
[TBL] [Abstract][Full Text] [Related]
2. Disposition of a new, nonsteroid, antiandrogen, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide (Flutamide), in men following a single oral 200 mg dose.
Katchen B; Buxbaum S
J Clin Endocrinol Metab; 1975 Aug; 41(2):373-9. PubMed ID: 1159048
[TBL] [Abstract][Full Text] [Related]
3. The effects of a nonsteroid antiandrogen, flutamide, on sebaceous gland activity.
Lutsky BN; Budak M; Koziol P; Monahan M; Neri RO
J Invest Dermatol; 1975 Jun; 64(6):412-7. PubMed ID: 1141714
[TBL] [Abstract][Full Text] [Related]
4. Effect of alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats.
Clark CR; Merry BJ; Nowell NW
J Reprod Fertil; 1981 Jan; 61(1):189-91. PubMed ID: 7452616
[TBL] [Abstract][Full Text] [Related]
5. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and pharmacokinetics of flutamide.
Neri R
Urology; 1989 Oct; 34(4 Suppl):19-21; discussion 46-56. PubMed ID: 2477934
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment.
Schulz M; Schmoldt A; Donn F; Becker H
Eur J Clin Pharmacol; 1988; 34(6):633-6. PubMed ID: 3169114
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of the anti-androgenic action of flutamide (alpha-alpha-alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide) in the rat.
Peets EA; Henson MF; Neri R
Endocrinology; 1974 Feb; 94(2):532-40. PubMed ID: 4810387
[No Abstract] [Full Text] [Related]
9. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
[TBL] [Abstract][Full Text] [Related]
10. [Anti-androgenic activity of various substituted carboxyanilides].
Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA
Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597
[TBL] [Abstract][Full Text] [Related]
11. Movement and Fate of p-Nitrophenyl-alpha,alpha,alpha-Trifluoro-2-Nitro-p Tolyl Ether-1'-C in Peanut Seedlings.
Eastin EF
Plant Physiol; 1969 Oct; 44(10):1397-401. PubMed ID: 16657216
[TBL] [Abstract][Full Text] [Related]
12. Further studies on the effects of flutamide on cortisol metabolism.
Fukushima DK; Smulowitz M; Levin J
Steroids; 1980 Feb; 35(2):209-17. PubMed ID: 7376219
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of o-[methyl-14C]toluidine in the F344 rat.
Son OS; Everett DW; Fiala ES
Xenobiotica; 1980; 10(7-8):457-68. PubMed ID: 7445517
[TBL] [Abstract][Full Text] [Related]
14. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
Frantz SW; Ballantyne B; Leung HW
Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
[TBL] [Abstract][Full Text] [Related]
15. [Participation of the hypothalamus in the pituitary and testicular responses to administration of the antiandrogen 4-nitro-3-trifluoro-methylisobutyranilide].
Reznikov AG; Volkova NN
Biull Eksp Biol Med; 1979 Nov; 88(11):601-3. PubMed ID: 120207
[TBL] [Abstract][Full Text] [Related]
16. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
17. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
[TBL] [Abstract][Full Text] [Related]
18. Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species.
Amadio J; Murphy CD
Biotechnol Lett; 2011 Feb; 33(2):321-6. PubMed ID: 20931353
[TBL] [Abstract][Full Text] [Related]
19. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous absorption of 14C-labelled 2-chlorobenzaldehyde in rats. Metabolism and toxicokinetics.
Rietveld EC; Hoet RM; Seutter-Berlage F; Van Rossum JM
Eur J Drug Metab Pharmacokinet; 1988; 13(4):231-40. PubMed ID: 3243317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
